Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2024)
Historic Non Operating Income for Eton Pharmaceuticals (ETON) over the last 6 years, with Q4 2024 value amounting to -$1.1 million.
- Eton Pharmaceuticals' Non Operating Income fell 702500.0% to -$1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.2 million, marking a year-over-year decrease of 34075.55%. This contributed to the annual value of -$1.2 million for FY2024, which is 34075.55% down from last year.
- Eton Pharmaceuticals' Non Operating Income amounted to -$1.1 million in Q4 2024, which was down 702500.0% from -$8000.0 recorded in Q3 2024.
- Over the past 5 years, Eton Pharmaceuticals' Non Operating Income peaked at $676000.0 during Q2 2023, and registered a low of -$1.1 million during Q4 2024.
- For the 5-year period, Eton Pharmaceuticals' Non Operating Income averaged around -$149900.0, with its median value being -$171000.0 (2020).
- Its Non Operating Income has fluctuated over the past 5 years, first surged by 41009.17% in 2023, then crashed by 702500.0% in 2024.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Non Operating Income stood at -$267000.0 in 2020, then decreased by 3.0% to -$275000.0 in 2021, then surged by 45.45% to -$150000.0 in 2022, then soared by 89.33% to -$16000.0 in 2023, then plummeted by 7025.0% to -$1.1 million in 2024.
- Its Non Operating Income was -$1.1 million in Q4 2024, compared to -$8000.0 in Q3 2024 and -$52000.0 in Q2 2024.